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Abbreviations:   
ACR, acute cellular rejection 
CAV, cardiac allograft vasculopathy 
CML, cell mediated lympholysis 
MHC, major histocompatibility complex 
MLR, mixed-lymphocyte reaction 
POD, post-operative day 
PBL, peripheral blood leukocytes 
PSL, percent specific lysis 
SLA, swine lymphocyte antigen 




We have previously shown that 12 days of high-dose calcineurin inhibition induced tolerance in 
MHC inbred miniature swine receiving MHC-mismatched lung, kidney, or co-transplanted 
heart/kidney allografts. However, if lung grafts were procured from brain dead donors, and 
transplanted alone, they were rejected within 19-45 days. Here, we investigated whether donor 
brain death with or without allograft ischemia would also prevent tolerance induction in kidney 
or heart/kidney recipients.  Four kidney recipients treated with 12 days of calcineurin inhibition 
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treated with calcineurin inhibition received organs from donors rendered brain dead for 4 hours, 
8 hours or 4 hours with 4 additional hours of cold storage. In contrast to lung allograft recipients, 
all isolated kidney or heart/kidney recipients that received organs from brain dead donors 
achieved long term survival (> 100 days) without histologic evidence of rejection. Pro-
inflammatory cytokine gene expression was upregulated in lungs and hearts, but not kidney 
allografts after brain death.  These data suggest hat the deleterious effects of brain death and 
ischemia on tolerance induction are organ-specific, which has implications in the application of 
tolerance to clinical transplantation. 
Introduction 
Clinical studies have demonstrated that long-term tolerance can be achieved in human recipients 
of kidney allografts (1). However, kidney allografts transplanted into these patients were 
procured from living-related donors and transplanted with short ischemic times. Thus, the donor 
organs had not been exposed to the highly inflammatory milieu consequent to brain death, nor 
had they been exposed to prolonged ischemia. Given the deleterious effects of brain death and 
ischemia on organ function and allograft survival (2), it is necessary to understand how brain 
death and ischemia affects tolerance induction before extending tolerance protocols proven 
successful in recipients of living-donor organs to recipients of cadaveric-donor organs. 
 
Our laboratory has previously studied the effects of brain death in a lung transplantation model 
using MHC-inbred miniature swine. We showed that a 12-day course of high-dose tacrolimus 
induced long-term tolerance in recipients of fully MHC-mismatched lung allografts procured 
from healthy, non-brain-dead donors. However, when lung allografts were procured from donors 
rendered brain dead and mechanically ventilated for four hours prior to organ procurement, they 
were all rejected within 45 days (3). These data confirm, in a preclinical model, that the 
deleterious effects of brain death in thedonor have the potential to render an otherwise 
successful tolerance protocol ineffective. 
 
In separate tolerance studies using miniature swine, it has been shown that a 12-day course of 
high-dose tacrolimus could also induce tolerance in recipients of fully MHC-mismatched kidney 
allografts (4), but not of heart allografts.  In fact, when isolated heart allografts were transplanted 

















This article is protected by copyright. All rights reserved 
rejected within 40 days (5).  However, when heart and kidney allografts from the same MHC-
mismatched donor were co-transplanted under a 12-day course of tacrolimus, recipients 
uniformly became tolerant of both organs (5). These studies demonstrate that the ability of a 
particular tolerance protocol to induce long-term unresponsiveness is organ-specific (6). 
 
Given the striking organ-specific differences we have observed in the ability of tolerance 
induction protocols to achieve immune unresponsiveness, we asked whether the effects of brain 
death and ischemia on tolerance induction would also differ depending on the organ transplanted. 
Here we show that in contrast to lung allograft recipients, donor brain death and prolonged organ 
ischemia did not prevent tolerance induction in isolated kidney or heart plus kidney allograft 
recipients. 
 
Material and Methods 
Animals 
Transplant donors and recipients were select d from our herd of MHC inbred miniature swine 
(age, 3-6 months; weight, 15-50 kg) (7 .  Swine leukocyte antigen (SLA)gg (MHC class Ic/IId) 
donor organs were transplanted into SLAdd (MHC class Id/IId) recipients to achieve a 2-
haplotype, class I MHC mismatch, while  SLAdd (MHC class Id/IId) donor organs were 
transplanted into SLAcc (MHC class Ic/II c
 
) recipients to achieve a 2-haplotype, full MHC 
mismatch. All animal care and procedures were approved by the Massachusetts General Hospital 
Institutional Animal Care and Use Committee and conducted in compliance with the Guide for 
the Care and Use of Laboratory Animals.   
Experimental groups 
Eight miniature swine received combined heart and kidney allografts from the same fully MHC 
disparate donors and were treated with a 12-day course of tacrolimus. Organs in Group 1 
recipients were procured from donors rendered brain dead for 4 hours (n=2). Organs in Group 2 
were procured from donors rendered brain dead for 8 hours (n=2). Organs in Group 3 were 
procured from donors rendered brain dead for 4 hours then stored for 4 additional hours in 
University of Wisconsin solution on ice (n=2). Group 4 animals received a combined 
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renal artery clamping for 80 minutes so as to induce a period of warm ischemic injury in the 
kidney graft.  Group 5 animals underwent bilateral native nephrectomies then rec ived isolated 
MHC class I-disparate kidney allografts from donors rendered brain dead for 4 hours and a 12-
day course of cyclosporine (n=4). Recipients were followed for over 3 months and regarded 
tolerant if, at POD 100, heart allografts showed strong contractions with no signs of rejection on 
biopsy and recipients had normal creatinine levels with no rejection on kidney biopsy. 
 
Operative procedures 
Donor brain death and cold ischemia. Under general anesthesia, brain death was induced by 
intracranial inflation of a 30 cc Foley catheter over a period of one minute (3) which elicited a 
Cushing response.  All donors were mechanically ventilated and similarly supported with 
crystalloid fluids and dopamine to maintain an adequate blood pressure for 4 or 8-hours 
following brain death. Organs in Group 1, 2, 4, and 5 were transplanted immediately after organ 
procurement. Organs in Group 3 were stored in University of Wisconsin solution on ice t 
prolong the cold ischemic times; 3 hours for kidneys, 4 hours for hearts (as hearts were 
implanted after the kidneys). 
 
Heart and kidney transplantation. Recipients underwent bilateral nephrectomy.  The aorta and 
inferior vena cava were used for end-to-side arterial and venous anastomoses for both the heart 
and kidney, with the heart placed on the right and the kidney on the left in cases of heart/kidney 
co-transplantation.  A vesicoureteral anastomosis was performed as part of the kidney 
implantation (8). 
 
Renal artery clamping. The laparotomy was re-opened and, after heparin administration (200 
units/kg), the renal artery was clamped for 80 minutes with a bulldog clamp. Twenty-four hours 
after clamping, a kidney biopsy was performed to evaluate the degree of ischemic injury. 
Kidney-injury molecule-1 (KIM-1), a transmembrane protein that is specifically up-regulated in 
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Skin grafting. Split-thickness skin grafts were placed on the dorsum of long-term tolerant 
recipients in Group 4.  Animals received fresh (self: SLAcc) or frozen (donor: SLAdd, third party: 
SLAll
 
) skin grafts.  
Immunosuppression and rejection monitoring 
Tacrolimus (Haorui Pharma-Chem Inc., Irvine, CA) was administered as a continuous infusion at 
a dose of 0.08-0.20 mg/kg (target trough level of 30-50 ng/ml) for 12 consecutive days, starting 
on the day of transplantation. Cyclosporine was given as a daily intravenous infusion over 1 hour 
(13 to 16 mg/kg/day with target levels 400 to 800 ng/mL) for 12 consecutive days, starting on the 
day of transplantation. Cardiac allograft rejection was defined by either loss of a ventricular 
impulse on palpation, and/or the lack of ventricular contraction on echocardiography.  Renal 
allograft rejection was defined as sustained rise in serum creatinine o >10 mg/dL and/or uremia.  
 
Histopathological examination 
Scoring of acute rejection on cardiac allograft biopsies was based on the International Society for 
Heart and Lung Transplantation System (10).  Acute rejection in kidney allograft biopsies was 
scored according to the Banff classification (11).  Some kidney samples were also stained with 
an anti-mouse/rat FoxP3 antibody (clone: FJK-16s, eBioscience, Inc., San Diego, CA). 
 
Cell-mediated lympholysis (CML) assay 
Effector cells were incubated with target cells at effector/target ratios of 100:1, 50:1, 25:1, and 
12.5:1. Two target cells were tested in each assay: (1) PBLs SLA matched to the onor (SLAdd: 
class Idd and class IIdd), and (2) third-party PBLs. 51
 
Cr release was determined on a gamma 
counter (Micromedics, Huntsville, AL). The results were expressed as a percentage of specific 
lysis and calculated as follows: Percentage of specific lysis = ((Experimental release [cpm] − 
Spontaneous release [cpm]) / (Maximum release [cpm] − Spontaneous release [cpm])) × 100 (5). 
Mixed lymphocyte reaction (MLR) assay 
Cultures containing 4 x 106 responder and 4 x 106 irradiated (2500 cGy) stimulator PBMCs were 
incubated for 5 days after which 1 uCi of [3H]-thymidine was added to each well. [3H]-
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Absolute counts were compensated for background and then expressed as stimulation indices 
(SI), calculated as SI = average cpm for a responder– stimulator pair per cpm of the same 
responder stimulated by an autologous stimulator (5). 
 
Flow cytometry 
The presence of anti-donor immunoglobulin (IgM and IgG) in the serum of experimental swine 
was examined by flow cytometry using a Becton Dickinson FACScalibur (Sunnyvale, CA) as 
previously described (5).   
 
Immunofluorescence staining for KIM-1 
Tissue from a kidney biopsy performed 24 hours after renal artery clamping was stained with the 
anti-pig-KIM -1 antibody as described previously (12).   
 
Quantitative PCR 
Kidney, lung, and heart biopsy specimens obtained before and after brain death were submerged 
in RNAlater (Qiagen, Valencia, CA, USA) and snap-frozen in liquid nitrogen.  RNA was 
isolated from tissue (Qiagen RNeasy Mini Kit) and used to derive first-strand cDNA (Invitrogen 
cDNA Synthesis Kit).  Fold change difference was calculated using the double delta Ct method, 
and all samples were normalized to GAPDH. qPCR primers were synthesized based on 
previously published reports of swine-specific assays for IL-1, IL-6, TNF-α, IFN-γ and GAPDH 
(13).   
 
Results 
Donor brain death did not prevent tolerance induction in recipients of co-transplanted 
heart and kidney allografts or isolated kidney allografts. 
We have previously demonstrated that MHC-mismatched recipients of co-transplanted heart/ 
kidney allografts from the same healthy, non-brain dead donors all became tolerant of their 
allografts after a 12-day course of tacrolimus and survived long term (5). Table I shows that 
long-term, stable tolerance was still observed in uncomplicated recipients which received fully 
MHC-disparate heart and kidney allografts from donors rendered brain dead for 4 hours (Group 
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survived over 100 days without any histologic evidence of rejection on serial cardiac biopsies 
(Fig S1a). Serial CML assays (Fig 1a) and MLR (Fig 1b) assays demonstrated the loss of host 
anti-donor T cells responses by PODs 30-60, while serial FACS analysis revealed the absence of 
significant alloantibody levels at any time point (Fig S2). One animal (#21505) died on POD 16 
from pulmonary embolism. Another animal (#22029) developed recurrent pneumonias with 
septicemia (Gram+ cocci and Gram- rods), requiring intravenous antibiotic (vancomycin, 
piperacillin/tazobactam) treatment for several weeks. However, despite this prolonged 
inflammatory state, recipient #22029 continued to exhibit donor-specific unresponsiveness in in 
vitro assays with only minimal changes on cardiac biopsies (Table I).  
 
The kidney allografts in these recipients all maintained normal function as evidence by serial 
creatinine levels despite the finding of a variable mononuclear cellular infiltrate classified as 
Banff borderline or TCMR I (Figure S1b).  The infiltrates often formed organized aggregates 
around arterioles and small arteries rich in FoxP3+ cells (Fig S1c) similar to the Treg
 
-rich 
organized lymphoid structures (TOLS) that we have observed in spontaneously accepted murine 
kidney allografts (14). TOLS were seen as early as 16 days (#21505) and were present in 10/11 
allograft kidneys at 3 months (Table 1) but were not observed in the heart allografts. 
Donor brain death had no effect on recipients of isolated kidney allografts, as long-term stable 
tolerance was also bserved in all cyclosporine-treated recipients receiving class I disparate 
kidney allografts from donors rendered brain dead for 4 hours (Table I, Group 5).  Although the 
protocol used in Group 5 varied from the Groups 1-4, previous studies in MHC-inbred miniature 
swine indicate that the rejection response and survival of class I-disparate kidney (15) or heart 
allografts (8) transplanted under the cover of cyclosporine mimic that of fully MHC-disparate 
kidneys (4) or hearts (5) transplanted under the cover of tacrolimus.  Isolated cardiac allografts 
were not tested in this brain death study as hearts from non-brain dead donors were all rejected 
within 40 days (5). 
 
Comparison of donor brain death effects in recipients of MHC disparate heart/kidney 
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To demonstrate the organ-specific effects of brain death on tolerance induction, we compared the 
survival times of recipients co-transplanted with heart/kidney allografts from brain dead donors 
to recipients of brain-dead lung allografts (data published previously (3)). In this comparison, all 
brain-dead allografts were retrieved four hours after intracerebral injury and all allografts were 
transplanted across a full MHC barrier with the same 12-day course of tacrolimus. Figure 2 
shows the clear organ-specific differences in the effects of brain death on tolerance; recipients of 
brain-dead lungs all rejected by postoperative day 45, whereas recipients of brain dead kidneys 
or heart/kidney allografts survived long term. 
 
Organ-specific changes in tissue cytokine gene expression after brain death.  
To determine the inflammatory effects of brain death, we measured the change in cytoki e gene 
expression of TLR2, TLR4, IL-1, IL-6, TNF α, and IFNγ in donor organs.  Kidney, lung, and 
heart tissue was collected from animals (n=4 for kidney, n=3 for lung, n=2 for heart) before and 
4 hours after induction of brain death. Quantitative PCR was performed and fold change in gene 
expression was calculated before normalizing to GAPDH.  There was little change in RNA 
levels of cytokine gene expression in the kidneys (Fig 3a). In contrast, substantial increases in 
RNA for IL-1 and IL-6 were observed in 2/3 lungs and in 2/2 hearts after brain death (Fig 3b and 
c).   
 
Cold ischemia in addition to brain death did not prevent the induction of tolerance of heart 
and kidney allografts. 
When the heart and kidneys were exposed to a 3-4 hour period of cold ischemia n addition to the 
four hour period of brain death, long-term stable tolerance was still achieved (Table I, Group 3).  
Serial heart biopsies showed no rejection and i  vitro assays revealed no anti-donor T or B cell 
responses after 3 months (Table I). The only difference noted in this group was the cardiac 
allograft’s greater susceptibility to ventricular arrhythmia after reperfusion.  
 
Warm ischemic renal injury induced by renal artery clamping did not prevent the 
induction of tolerance. 
Two additional heart/kidney transplants were performed using organs from healthy, non-brain 
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operating room on POD 2 to undergo in situ donor renal artery clamping for 80 minutes (Table I, 
Group 4).  This resulted in a sharp increase in serum creatinine in both recipients with levels 
peaking between 4 and 6 mg/dL 72 hours after the ischemic insult. However, creatinine levels 
gradually decreased to baseline levels over a period of two weeks. Kidney biopsies performed 24 
hours after clamping and stained for KIM-1 confirmed that the renal tubule epithelium had 
suffered an ischemic injury (compare Fig S1d and e). Despite this extended period of warm 
ischemia with documented tubular injury, both recipients accepted the heart and kidney 
allografts long term and showed no anti-donor T cell (Fig 1c and 1b) or B cells responses. Serial 
biopsies showed no signs of cellular rejection in the heart (Fig S1f) and minimal infiltrate in the 
kidney (Table I).  
 
Donor-specific (SLAdd) and third-party (SLAll
 
) skin grafts were placed on the Group 4 recipients 
on PODs 97 (#21736) and 98 (#21420).  The third-party skin grafts were rejected within 10 days; 
however, the donor-specific skin grafts urvived to days 35 (#21420) and 62 (#21736). Of note, 
serial biopsies of the heart and kidney allografts in both recipients showed no evidence of 
rejection well after rejection of donor skin (over 60 days). This finding demonstrates that even 
after an ischemic insult the tolerogenic kidney is able to induce and maintain a robust state of 
unresponsiveness. 
Discussion 
The recent successes achieved in inducing tolerance in human recipients of living-donor kidney 
allografts has prompted investigators to consider applying the same protocols to recipients of 
organs procured from brain-dead donors1
                                                            
1
 Request for Proposals from the Immune Tolerance Network (ITN) entitled “Clinical Trials of 
Immune Tolerance in Transplantation using Deceased Donor Organs” at 
.  However, there is little experimental literature to 
guide this new initiative, as most small- and large-animal tolerance studies have used organs 
from healthy, non-brain-dead donors transplanted under optimal circumstances with very short 
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brain death can render ineffective a tolerance protocol that was otherwise uccessful in recipients 
receiving lungs from healthy, non-brain-dead donors (Fig 2)(3). 
 
Previously documented organ-specific differences in tolerance induction (4, 5) led us to consider 
whether the effects of brain death and ischemia on tolerance induction would also differ 
depending on the organ transplanted. Here we demonstrate that, in contrast to lung allograft 
recipients, brain death and ischemia (cold and warm) did not prevent tolerance induction in 
isolated kidney or heart plus kidney recipients. These findings suggest that, like tolerance, the 
effects of donor brain death and ischemia vary with the organ transplanted. 
 
The effect of donor brain death and organ ischemia on organ quality has been studied 
extensively; however, investigations into the effect of brain death and ischemia on tolerance 
induction are limited. Francuski et al (16) showed that donor brain death affected the long term 
function and histology of rat kidneys transplanted into recipients treated with 10 days of CyA 
and anti-CD4 mAb therapy, but it did not have an effect on overall graft survival. The same 
group demonstrated that extended cold ischemia did not interfere with the induction of rat kidney 
allograft tolerance using anti-CD4 mAb treatment (17). These findings are in line with our 
results in porcine recipients of isolated kidney allograft. However, to our knowledge, comparable 
studies evaluating the effects of brain death on tolerance in heart or lung allograft recipients have 
not been performed.   
 
Our finding that isolated kidney recipients and heart/kidney recipients were spared from the 
deleterious effects of brain death and ischemia (in contrast to lung allografts) uggests an organ-
specific mechanism which has not been previously described. These results extend our earlier 
studies using non-brain-dead donors by showing that not only are kidney allografts able to 
conferring tolerance on otherwise tolerance-resistant hearts (5), but also that they possess an 
intrinsic ability to counter the deleterious effects of brain death and ischemia on tolerance 
induction.  
 
To investigate the mechanisms underlying these organ-specific differences, we measured the 

















This article is protected by copyright. All rights reserved 
kidney, heart and lung tissue after 4 hours of brain death.  Little change in RNA levels of 
cytokine gene expression was observed in kidney tissue but substantial increases in RNA for IL-
1 and IL-6 were observed in lung and heart tissue after brain death.  These organ-specific 
differences in gene expression following brain death are consistent with previous rep rt  in the 
literature(18, 19) 
 
These findings suggest that the differential effects observed after brain death observed in our 
study results from organ-specific differences in the upregulation of pro-inflammatory genes like 
IL-6 versus protective genes such as HO-1 .  This theory posits that following brain death, the 
balance of protective gene expression versus inflammatory gene expression in kidney allografts 
favors a protective milieu, allowing for the induction of tolerance; whereas in lung allografts, 
that balance is shifted towards a more pro-inflammatory state which tilts the overall immune 
response from tolerance toward rejection. Recently, Zheng et al. (20) demonstrated a population 
of donor-derived, nonclassical monocytes retained in donor lung grafts that may explain the pro-
inflammatory nature of these allografts. 
 
In summary, our results show that the deleterious effects of brain death and ischemia on 
tolerance induction differ depending on the organ transplanted, with kidney being more resistant 
to the effects of brain death and ischemia than lungs. Moreover, kidney allografts from brain 
dead donors are capable of extending their protective effects to co-transplanted brain dead heart 
allografts.  These findings suggest that attempts to apply tolerance induction protocols to 
recipients of extra-renal, brain dead organs may require separating in time the organ implantation 
and the initiation of a tolerance protocol. Indeed, we have shown that delaying the induction of 
tolerance until the inflammatory state associated with brain death and I/R injury dissipates i  
both feasible and effective (21). 
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Figure 1: a) Serial cell-mediated lympholysis (CML) assays using responder cells from animal 
#21690. Pre-transplant anti-donor responses (blue) were lost by POD 62 but strong responses 
against 3rd party antigen (Yorkshire PBMC) (red) persisted. b) Representative mixed-lymphocyte 
reaction (MLR) assays. In animal #21690 and animal #21420 pre-transplant anti-donor responses 
were lost by POD 30 (blue) but strong response against 3rd party antigen (Yorkshire PBMC) 
(red) persisted. c) Serial CML assays using responder cells from animal #21736. Pre-transplant 
anti-donor responses were lost by POD35 (blue) but strong responses against 3rd
 
 party antigen 
(Yorkshire PBMC) (red) persisted. 
Figure 2: Donor brain death effects in recipients of heart/kidney versus lung allografts. Survival 
times of brain dead heart and kidney allograft recipients (solid line) are compared to the survival 
times of non-brain dead lung allograft recipients (dotted line) and brain dead lung allograft 
recipients (dashed line). The lung allograft data was published previously (3). 
 
Figure 3: Change in tissue gene expression after brain death. qPCR was performed on RNA 
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hours after induction of brain death. Fold change difference was calculated using the double 
delta Ct method, and all samples were normalized to GAPDH. 
 
Supporting Information 
Additional Supporting Information may be found online in the supporting information tab for 
this article. 
 
Figure S1: Histology of heart and kidney allografts. (a) H&E staining of heart tissue biopsied 
from animal #21690 on POD 113 and graded as ISHLT 0. (b) PAS staining and (c) FoxP3 
staining (brown) of kidney tissue biopsied from animal #21690 on POD 113. Focally dense 
infiltrates contain abundant Foxp3+ cells (resembling Treg-rich organized lymphoid structures 
(TOLS) (14). KIM-1 immunofluorescence staining of renal tubular epithelial cells in animal 
#21420 before (d) and 24 hours after (e) renal artery clamping (nuclei staining blue, KIM-1 
staining green). Negative controls were incubated with the secondary antibody only and did not 
show significant staining (data not shown). (f  H&E staining of heart tissue biopsied from animal 
#21736 on POD 97 and graded as ISHLT 0. 
 
Figure S2: Serum alloantibody levels in heart/kidney recipients.  Serum levels of anti-SLAdd
 
 
IgM and IgG antibodies were measured by flow cytometry. Data were normalized to the mean 
fluorescence intensity (MFI) of negative control values to plot normalized MFI as a function of 
postoperative day.  Dotted line represents the average normalized MFI of positive control serum.  
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Table 1: Graft survival, histology of heart-kidney and isolated kidney recipients 









Brain death x 4hrs 
21690 >100 days 





(died of PE) 
n/a (i0t1+TOLS  





Brain death x 8hrs 
22025 >100 days 
Heart: ISHLT 0R 
Kidney: 
i1t3+TOLS 
22029 >100 days 







Brain death x 4hrs  
Cold ischemia x 4hrs  
21740 >100 days 
Heart: ISHLT 0R 
Kidney: 
i1t2+TOLS 
22026 >100 days 
Heart: ISHLT 0R 
Kidney:  





Warm renal ischemia x 
80mins   
 
21420 >100 days 
Heart: ISHLT 0R 
Kidney: 
i1t2+TOLS 
21736 >100 days 







Brain death x 4hrs 
18055 >100 days i1t2+TOLS 
18225 >100 days i0t3+TOLS 
18226 >100 days i1t2+TOLS 
18353 >100 days i0t2+TOLS 
POD, postoperative day; ISHLT, International Society for heart and lung transplantation; ACR, 
acute cellular rejection; PE, pulmonary embolism; TOLS, Treg-rich Organized Lymphoid 
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